Controversial treatment of atherosclerotic renal vascular disease: the cardiovascular outcomes in renal atherosclerotic lesions trial
- PMID: 16864748
- DOI: 10.1161/01.HYP.0000233513.19720.b7
Controversial treatment of atherosclerotic renal vascular disease: the cardiovascular outcomes in renal atherosclerotic lesions trial
Similar articles
-
The Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study: rationale and methods.J Vasc Interv Radiol. 2005 Oct;16(10):1295-300. doi: 10.1097/01.RVI.0000176301.69756.28. J Vasc Interv Radiol. 2005. PMID: 16221898 No abstract available.
-
Influence and critique of the ASTRAL and CORAL Trials.Semin Vasc Surg. 2011 Sep;24(3):162-6. doi: 10.1053/j.semvascsurg.2011.11.001. Semin Vasc Surg. 2011. PMID: 22153027 Review.
-
Did renal artery stent placement fail in the Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL) study or did the CORAL Study Fail Renal Artery Stent Placement? The CORAL roll-in experience and the CORAL trials.J Vasc Interv Radiol. 2014 Apr;25(4):520-3; quiz 524. doi: 10.1016/j.jvir.2013.12.569. J Vasc Interv Radiol. 2014. PMID: 24674209 No abstract available.
-
Part two: the vast majority of patients with atherosclerotic renal artery stenoses do not require intervention.Eur J Vasc Endovasc Surg. 2011 Aug;42(2):139-43. doi: 10.1016/j.ejvs.2011.06.003. Eur J Vasc Endovasc Surg. 2011. PMID: 21816339 No abstract available.
-
Percutaneous Revascularization for Atherosclerotic Renal Artery Stenosis: A Meta-Analysis of Randomized Controlled Trials.Ann Vasc Surg. 2015 Oct;29(7):1457-67. doi: 10.1016/j.avsg.2015.06.062. Epub 2015 Jul 11. Ann Vasc Surg. 2015. PMID: 26173202 Review.
Cited by
-
Angiotensin receptor blockade has protective effects on the poststenotic porcine kidney.Kidney Int. 2013 Oct;84(4):767-75. doi: 10.1038/ki.2013.144. Epub 2013 Apr 24. Kidney Int. 2013. PMID: 23615504 Free PMC article.
-
Atherosclerosis renal artery stenosis and in-stent restenosis in a diabetic patient: Targeting on diabetic dyslipidemia is a key intervention.J Endocrinol Invest. 2010 Apr;33(4):284-5. doi: 10.1007/BF03345794. Epub 2009 Oct 15. J Endocrinol Invest. 2010. PMID: 19834317 No abstract available.
-
Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular disease.Kidney Int. 2014 Apr;85(4):833-44. doi: 10.1038/ki.2013.477. Epub 2013 Dec 18. Kidney Int. 2014. PMID: 24352153 Free PMC article.
-
Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.Am J Physiol Renal Physiol. 2011 Jul;301(1):F218-25. doi: 10.1152/ajprenal.00089.2011. Epub 2011 Apr 6. Am J Physiol Renal Physiol. 2011. PMID: 21478482 Free PMC article.
-
Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.J Clin Hypertens (Greenwich). 2014 Jul;16(7):497-503. doi: 10.1111/jch.12341. Epub 2014 Jun 7. J Clin Hypertens (Greenwich). 2014. PMID: 24909590 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical